Hugo Espinoza
Psychiatric/Mental Health · Lynchburg, VANPI 1417207051
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $9,756 of the $12,502 with a category attached, or 78.0%. Johnson & Johnson accounts for 90.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $10,308, more than ten times the $272 reported in 2021. Among psychiatric/mental health clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $277.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$11K
- Alkermes, Inc.$397
- Neurocrine Biosciences, Inc.$145
- Abbott$144
- Otsuka America Pharmaceutical, Inc.$140
- Teva Pharmaceuticals USA, Inc.$121
- plus $265 from 4 others
What the payments were for
- Food & beverage$2,68321%
- Education$631%
- Gifts$9,75678%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 26 | $11,289 |
| Alkermes, Inc. | 8 | $397 |
| Neurocrine Biosciences, Inc. | 2 | $145 |
| Abbott | 1 | $144 |
| Otsuka America Pharmaceutical, Inc. | 2 | $140 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| Amgen | 1 | $108 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $104 |
| Lundbeck LLC | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$904
- INVEGA TRINZA$529
- ARISTADA$500
- LYBALVI$451
- CARDIOMEMS$144
- INGREZZA$125
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- ARISTADA INITIO$125
- UZEDY$121
- Tavneos$108
- CAPLYTA$104
- SPRAVATO$101
How this compares
$12,502 in reported general payments places this provider in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega TrinzaPaliperidone Palmitate | 16 | $164,976 |
| Invega SustennaPaliperidone Palmitate | 32 | $85,331 |
| Abilify MaintenaAripiprazole | 22 | $68,230 |
| Aripiprazole | 89 | $7,812 |
| Lurasidone Hcl | 43 | $3,540 |
| Clozapine | 31 | $2,245 |
| Buspirone Hcl | 123 | $2,109 |
| Trazodone Hcl | 174 | $1,994 |
| Risperidone | 165 | $1,627 |
| Quetiapine Fumarate | 91 | $1,620 |
| Hydroxyzine Hcl | 99 | $1,601 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 63 | $1,400 |
| Duloxetine Hcl | 55 | $1,348 |
| Olanzapine | 79 | $1,328 |
| LoxapineLoxapine Succinate | 11 | $1,199 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Trinza, Invega Sustenna | $11,289 | $250,30848 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $140 | $68,23022 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $121 | $1,19911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.
Other psychiatric/mental health in Lynchburg
- Michele MorganLynchburg$8K
- Justin RayChesapeake$127K
- Katia HallChesapeake$88K
- Christine GilmoreBedford$75K
- Sarah FaberNewport News$59K
- Kristine GarciaGlen Allen$46K
- Tonjanika BoydRichmond$40K
- Kirby PatmonRichmond$36K
- Juliana FroschAmherst$36K
- Derick ReedyNickelsville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.